There were 910 press releases posted in the last 24 hours and 439,213 in the last 365 days.

Gazprom and Shell sign roadmap for third train of Sakhalin II project

February 23, 2014, 12:25

Sochi hosted today the signing of a memorandum-roadmap between Alexey Miller, Chairman of the Gazprom Management Committee and Ben van Beurden, Chief Executive Officer of Shell.

The document envisages the preparation of FEED documentation for the third LNG production train within the Sakhalin II project.

“The global LNG market is booming – primarily in Asian countries. Novel LNG production capacities are the key to achieving a strong position in this market,” said Alexey Miller.

“We welcome the sequential approach of our strategic partner Gazprom to expanding the LNG plant in the Prigorodnoye settlement. The third train will help confirm the status of the Sakhalin II project as a reliable energy supplier to the Asia-Pacific region,” said Ben van Beurden, Chief Executive Officer of Shell.

Background

Sakhalin Energy is the Sakhalin II project operator. The company is owned by Gazprom (50 per cent plus one share), Shell (27.5 per cent minus one share), Mitsui & Co. (12.5 per cent) and Mitsubishi Corporation (10 per cent).

As part of the project, Russia's first LNG plant was commissioned in early 2009 and consumers abroad started receiving LNG from Russia. In 2010 the plant reached its full capacity of 9.6 million tons per annum. A total of 10.8 million tons of LNG and 5.4 million tons of oil were produced within the Sakhalin II project in 2013.

Shell is a British-Dutch oil and gas company focused on hydrocarbons production, processing and marketing in over 90 countries worldwide.

 

Media

+7 495 719-10-77 +7 495 719-49-37 +7 495 719-47-36 +7 495 719-28-01

pr@gazprom.ru

Investment Community

+7 495 719-34-83 ir@gazprom.ru

 

All news for February 2014

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.